Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Boston Pharma Appoints Ian Sanderson as CFO | Contract Pharma
Promotions & Moves

Boston Pharma Appoints Ian Sanderson as CFO

Accomplished healthcare finance leader to manage financial operations

Boston Pharmaceuticals has appointed Ian Sanderson as chief financial officer. As a member of Boston Pharmaceuticals’ senior leadership team, Mr. Sanderson will be involved with the company’s evaluation, acquisition, and development of differentiated clinical programs for the Boston Pharmaceuticals drug portfolio.

Robert Armstrong, chief executive officer and co-founder of Boston Pharmaceuticals said, “Ian has extensive expertise in the evaluation and financing of clinical development programs, and brings to Boston Pharmaceuticals critical perspectives to our analyses of potential new product opportunities. We welcome him to our leadership team and look forward to his transaction and strategic insights as we build our portfolio of development programs through mutually advantageous collaborations with our partner companies.”

Mr. Sanderson joins Boston Pharmaceuticals from Catabasis Pharmaceuticals, where he was chief financial officer. While at Catabasis, Mr. Sanderson oversaw operations and led the company’s re-positioning and successful IPO in 2015. Prior to joining Catabasis, Mr. Sanderson was a senior advisor with JSB Partners, advising life sciences companies on corporate finance, M&A and business development transactions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters